Erasmus University Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (22)

2024

  1. An autologous ex vivo model for exploring patient-specific responses to viro-immunotherapy in glioblastoma

    Cell Reports Methods, Vol. 4, Núm. 3

2023

  1. Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study

    Blood Cancer Journal

2022

  1. Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood

    Frontiers in Immunology, Vol. 13

  2. Quantitative proteomics of small numbers of closely-related cells: Selection of the optimal method for a clinical setting

    Frontiers in Medicine, Vol. 9

2021

  1. Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study

    Modern Pathology, Vol. 34, Núm. 1, pp. 59-69

  2. Monocyte subsets and serum inflammatory and bone-associated markers in monoclonal gammopathy of undetermined significance and multiple myeloma

    Cancers, Vol. 13, Núm. 6, pp. 1-18

  3. Monocytes carrying GFAP detect glioma, brain metastasis and ischaemic stroke, and predict glioblastoma survival

    Brain Communications, Vol. 3, Núm. 1

2020

  1. Corrigendum to “Flow cytometric assessment of leukocyte kinetics for the monitoring of tissue damage” [Clin Immunol 2018; 197: 224–230] (Clinical Immunology (2018) 197 (224–230), (S1521661618301207), (10.1016/j.clim.2018.09.014))

    Clinical Immunology

2019

  1. Distribution of subsets of blood monocytic cells throughout life

    Journal of Allergy and Clinical Immunology, Vol. 144, Núm. 1, pp. 320-323.e6

  2. Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples

    Journal of Immunological Methods, Vol. 475

  3. The presence of CLL-associated stereotypic B cell receptors in the normal BCR repertoire from healthy individuals increases with age

    Immunity and Ageing, Vol. 16, Núm. 1

2018

  1. Flow cytometric assessment of leukocyte kinetics for the monitoring of tissue damage

    Clinical Immunology, Vol. 197, pp. 224-230

  2. Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment

    Neuro-Oncology, Vol. 20, Núm. 11, pp. 1494-1504

2017

  1. Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature

    Oncotarget, Vol. 8, Núm. 40, pp. 68950-68963

2016

  1. Expression profile of novel cell surface molecules on different subsets of human peripheral blood antigen-presenting cells

    Clinical and Translational Immunology, Vol. 5, Núm. 9

  2. Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression

    Leukemia, Vol. 30, Núm. 1, pp. 124-130

  3. KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression

    Blood, Vol. 127, Núm. 6, pp. 761-768

2015

  1. Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: Diagnostic implications

    Modern Pathology, Vol. 28, Núm. 8, pp. 1138-1149

  2. Ex vivo identification and characterization of a population of CD13high CD105+ CD45- mesenchymal stem cells in human bone marrow

    Stem Cell Research and Therapy, Vol. 6, Núm. 1

2011

  1. The nature of circulating CD27 +CD43 + B cells

    Journal of Experimental Medicine